Infant Bacterial Therapeutics AB (IBT) is a pharmaceutical company dedicated to developing drugs that prevent diseases in premature infants and combat the spread of antibiotic-resistant illnesses. IBT’s primary focus is on IBP-9414, a drug candidate containing Lactobacillus reuteri, a bacterial strain found in breast milk. The aim of IBP-9414 is to reduce the occurrence of necrotizing enterocolitis (NEC) and improve sustained feeding tolerance (SFT) in premature infants. Currently, IBP-9414 is undergoing a pivotal Phase III study for registration. IBT also has other drug candidates, including IBP-1016 for treating gastroschisis, IBP-1118 for preventing retinopathy of prematurity (ROP), and IBP-1122 for eliminating vancomycin-resistant enterococci (VRE) causing hospital acquired infections. By developing these drugs, IBT addresses medical needs that lack available treatments.
Company Details
- Employees
- 13
- Founded
- -
- Address
- Bryggargatan 10, Stockholm,stockholm County 111 21,sweden
- in****@****ics.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- ibtherapeutics.com
- Keywords
- IT Consulting.
- HQ
- Stockholm, Stockholm County
Infant Bacterial Therapeutics Ab Questions
Infant Bacterial Therapeutics Ab's website is ibtherapeutics.com
Infant Bacterial Therapeutics Ab's LinkedIn profile is https://se.linkedin.com/company/infant-bacterial-therapeutics-ab
Infant Bacterial Therapeutics Ab has
13 employees.
View email and phone details for 13
employees at Infant Bacterial Therapeutics Ab.
Infant Bacterial Therapeutics Ab's industry is
Pharmaceutical Manufacturing
Infant Bacterial Therapeutics Ab's top competitors are
Mrm Health,
Protean Funds Scandinavia Ab,
Biosenic S.a.,
The Microbiome Times,
Biogaia Ab,
Xspray Pharma Ab (Publ),
Fast Track,
Scibase,
Microbiotica,
Sprint Bioscience.
Infant Bacterial Therapeutics Ab's support email address is info@ibtherapeutics.com
Infant Bacterial Therapeutics Ab's categories are Pharmaceutical Manufacturing
Infant Bacterial Therapeutics Ab's founding year is 2013
